Richard Finn transferred to UCLA as an undergraduate freshman from UC San Diego in the late 1970s to be closer to home after his mother died of breast cancer when he was a college freshman. Read more...
Photo: Dennis Slamon (left) and Richard Finn (right) developed Ibrance, a breast cancer drug that has been recently approved by the FDA. (UCLA Newsroom)